Cargando…
Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial
AIMS: Tranexamic acid (TXA) is now commonly used in major surgical operations including orthopaedics. The TRAC-24 randomized control trial (RCT) aimed to assess if an additional 24 hours of TXA postoperatively in primary total hip (THA) and total knee arthroplasty (TKA) reduced blood loss. Contrary...
Autores principales: | Karayiannis, Paul N., Agus, Ashley, Bryce, Leanne, Hill, J. C., Beverland, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350706/ https://www.ncbi.nlm.nih.gov/pubmed/35816170 http://dx.doi.org/10.1302/2633-1462.37.BJO-2021-0213.R1 |
Ejemplares similares
-
The impact of an enhanced recovery programme on length of stay and post-discharge resource usage following hip and knee arthroplasty: a service evaluation and cost analysis
por: Milligan, David J., et al.
Publicado: (2021) -
Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial
por: Hill, Janet, et al.
Publicado: (2018) -
Are patient-reported outcomes the same following second-side surgery in primary hip and knee arthroplasty?
por: Tucker, Adam, et al.
Publicado: (2021) -
Should isolated morbid obesity influence the decision to operate in hip and knee arthroplasty?
por: Crookes, Peter F., et al.
Publicado: (2021) -
Prolonged length of stay (PLOS) in a high-volume arthroplasty unit
por: Kang, Hean Wu, et al.
Publicado: (2020)